These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15466364)

  • 21. In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.
    Cochran BJ; Ryder WJ; Parmar A; Tang S; Reilhac A; Arthur A; Charil A; Hamze H; Barter PJ; Kritharides L; Meikle SR; Gregoire MC; Rye KA
    Diabetologia; 2016 Sep; 59(9):1977-84. PubMed ID: 27193916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter.
    Pearce NJ; Arch JR; Clapham JC; Coghlan MP; Corcoran SL; Lister CA; Llano A; Moore GB; Murphy GJ; Smith SA; Taylor CM; Yates JW; Morrison AD; Harper AJ; Roxbee-Cox L; Abuin A; Wargent E; Holder JC
    Metabolism; 2004 Oct; 53(10):1322-30. PubMed ID: 15375789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance.
    Castellani LW; Nguyen CN; Charugundla S; Weinstein MM; Doan CX; Blaner WS; Wongsiriroj N; Lusis AJ
    J Biol Chem; 2008 Apr; 283(17):11633-44. PubMed ID: 18160395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle expression of a malonyl-CoA-insensitive carnitine palmitoyltransferase-1 protects mice against high-fat/high-sucrose diet-induced insulin resistance.
    Vavrova E; Lenoir V; Alves-Guerra MC; Denis RG; Castel J; Esnous C; Dyck JR; Luquet S; Metzger D; Bouillaud F; Prip-Buus C
    Am J Physiol Endocrinol Metab; 2016 Sep; 311(3):E649-60. PubMed ID: 27507552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microarray analysis identifies human apoA-I
    Ganzetti GS; Parolini C
    Exp Cell Res; 2023 Dec; 433(1):113826. PubMed ID: 37858836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 700-bp fragment of the human antithrombin III promoter is sufficient to confer high, tissue-specific expression on human apolipoprotein A-II in transgenic mice.
    Tremp GL; Duchange N; Branellec D; Cereghini S; Tailleux A; Berthou L; Fievet C; Touchet N; Schombert B; Fruchart JC
    Gene; 1995 Apr; 156(2):199-205. PubMed ID: 7758957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance.
    Kim JK; Fillmore JJ; Chen Y; Yu C; Moore IK; Pypaert M; Lutz EP; Kako Y; Velez-Carrasco W; Goldberg IJ; Breslow JL; Shulman GI
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7522-7. PubMed ID: 11390966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contrasting in vivo effects of murine and human apolipoprotein A-II. Role of monomer versus dimer.
    Gong EL; Stoltfus LJ; Brion CM; Murugesh D; Rubin EM
    J Biol Chem; 1996 Mar; 271(11):5984-7. PubMed ID: 8626380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice.
    Tailleux A; Bouly M; Luc G; Castro G; Caillaud JM; Hennuyer N; Poulain P; Fruchart JC; Duverger N; Fiévet C
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2453-8. PubMed ID: 11073852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia.
    Allayee H; Castellani LW; Cantor RM; de Bruin TW; Lusis AJ
    Circ Res; 2003 Jun; 92(11):1262-7. PubMed ID: 12738753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein.
    Blanco-Vaca F; Escolà-Gil JC; Martín-Campos JM; Julve J
    J Lipid Res; 2001 Nov; 42(11):1727-39. PubMed ID: 11714842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal lymphatic HDL miR-223 and ApoA-I are reduced during insulin resistance and restored with niacin.
    Mangat R; Borthwick F; Haase T; Jacome M; Nelson R; Kontush A; Vine DF; Proctor SD
    FASEB J; 2018 Mar; 32(3):1602-1612. PubMed ID: 29183962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ApoA-II versus ApoA-I: two for one is not always a good deal.
    Castellani LW; Lusis AJ
    Arterioscler Thromb Vasc Biol; 2001 Dec; 21(12):1870-2. PubMed ID: 11742857
    [No Abstract]   [Full Text] [Related]  

  • 34. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
    Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
    J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.
    Coll T; Alvarez-Guardia D; Barroso E; Gómez-Foix AM; Palomer X; Laguna JC; Vázquez-Carrera M
    Endocrinology; 2010 Apr; 151(4):1560-9. PubMed ID: 20185762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies In apoA-II and hepatic lipase double knockout mice.
    Weng W; Brandenburg NA; Zhong S; Halkias J; Wu L; Jiang XC; Tall A; Breslow JL
    J Lipid Res; 1999 Jun; 40(6):1064-70. PubMed ID: 10357838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis.
    Chan DC; Ng TW; Watts GF
    Ann Med; 2012 Jun; 44(4):313-24. PubMed ID: 21501035
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats.
    Mullen KL; Pritchard J; Ritchie I; Snook LA; Chabowski A; Bonen A; Wright D; Dyck DJ
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R243-51. PubMed ID: 19073900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1.
    Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM
    Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.